Accelerate Diagnostics Cash Flow - Quarterly (NASDAQ:AXDX)

Add to My Stocks
$23 $0.35 (1.5%) AXDX stock closing price Sep 21, 2017 (Closing)

The Accelerate Diagnostics cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Accelerate Diagnostics profits one has to check the income statement and for Accelerate Diagnostics debt one has to check the balance sheet. Accelerate Diagnostics had cash and cash equivalents of $120.58M at beginning of quarter and $62.6M at quarter end for 2017-Q2. Accelerate Diagnostics cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Accelerate Diagnostics has a positive cash and cash equivalents change of $43.36M. View details of Accelerate Diagnostics cash flows for latest & last 40 quarters

show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Accelerate Diagnostics Net Income Cash Flow
-30.65M-14.2M-66.37M-50.23M-32.94M-15.07M-45.49M-32.33M-21.14M-8.89M
Depreciation Depletion Amortization Cash-Flow1.27M0.62M2.72M2M1.27M0.58M1.98M1.34M0.83M0.37M
Net Increase (Decrease) in Assets Liabilities-6.2M-5.14M1.54M1.12M-0.25M-0.39M--0.24M-0.22M-0.09M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net7.49M3.24M8.7M6.5M3.83M1.68M8.38M5.99M4.18M1.65M
Accelerate Diagnostics Net Cash from (used by) Operating Activities
-28.09M-15.46M-53.4M-40.6M-28.08M-13.2M-35.12M-25.24M-16.35M-6.96M
Increase (Decrease) in Prop Plant And Equipment-1.64M-0.22M-2.4M-2.3M-2.08M-1.68M-3.65M-2.59M-2.16M-1.19M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-14.37M4.28M-47.15M-49.91M-53.15M-32.81M0.98M-0.97M-0.06M1.95M
Other Cash Inflow (Outflow) from Investment Activities----------
Accelerate Diagnostics Net Cash from (used by) Invesment Activities
-16.01M4.05M-49.56M-52.21M-55.23M-34.49M-2.67M-3.56M-2.22M0.76M
Issuance (Purchase) of Equity Shares87.27M2.03M1.72M0.94M0.09M0.02M104.97M0.54M0.32M0.06M
Issuance (Repayment) of Debt Securities---0.01M-0.01M-0.01M-0.01M-0.14M-0.11M-0.07M-0.03M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities--0.05M0.05M0.17M-0.81M----
Accelerate Diagnostics Net Cash from (used by) Financing Activities
87.27M2.03M1.76M0.98M0.25M-0.79M104.82M0.43M0.25M0.03M
Effect of Exchange Rate Changes on Cash0.19M0.05M-0.12M-0.01M--0.04M----
Accelerate Diagnostics Net Change in Cash & Cash Equivalents
43.36M-9.32M-101.34M-91.85M-83.06M-48.55M67.02M-28.37M-18.33M-6.17M
Cash & Equivalents at Beginning of Year120.58M53.56M30.02M12.06M-0.77M0.28M0.86M1.23M1.39M
Cash & Equivalents at Year End62.6M9.91M19.24M28.73M37.51M72.03M120.58M25.19M35.23M47.39M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While Accelerate Diagnostics stock price history provides the price history of a stock, Accelerate Diagnostics stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
  • Accelerate Diagnostics saw an increase in Net Change in Cash and Cash Equivalents from $-9.32M in 2017-Q1 to $43.36M in 2017-Q2. Apart from the Accelerate Diagnostics stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-28.09M for AXDX.
  • Cash from investing stood at a negative value of $-16.01M for AXDX stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $87.27M for Accelerate Diagnostics. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.
.

Key Financial Ratios For Accelerate Diagnostics Cash Flow